T3D3685 - Ergometrine
| Record Information | |
|---|---|
| Version | 1.0 |
| Creation Date | 2010-04-21 17:59:34 UTC |
| Update Date | 2013-04-25 08:48:34 UTC |
| Accession Number | T3D3685 |
| Identification | |
| Common Name | Ergometrine |
| Description | Ergometrine is an alkaloid of the ergoline family. Like other ergoline alkaloids, it occurs in various species of vines of the Convolvulaceae (morning glory) family and in some species of lower fungi. Ergometrine can also be synthesized from (+)-lysergic acid and L-(+)-2-aminopropanol. It has medical use in obstetrics to facilitate delivery of the placenta and to prevent bleeding after childbirth by causing smooth muscle tissue in the blood vessel walls to narrow, thereby reducing blood flow. For this is usually combined with oxytocin (Syntocinon) as syntometrine. Long term exposure to some ergoline alkaloids can cause ergotism, a disease causing convulsive and gangrenous symptoms. (W721, W727, W730) |
| Compound Type |
|
| Chemical Structure |
|
| Synonyms |
|
| Chemical Formula | C19H23N3O2 |
| Average Molecular Weight | 325.4048 |
| Monoisotopic Molecular Weight | 325.179026995 |
| Chemical IUPAC Name | ergonovine |
| CAS Registry Number | 60-79-7 |
| SMILES | CC(CO)NC(=O)C1CN(C)C2CC3=CNC4=CC=CC(=C34)C2=C1 |
| InChI Identifier | InChI=1S/C19H23N3O2/c1-11(10-23)21-19(24)13-6-15-14-4-3-5-16-18(14)12(8-20-16)7-17(15)22(2)9-13/h3-6,8,11,13,17,20,23H,7,9-10H2,1-2H3,(H,21,24) |
| InChI Key | InChIKey=WVVSZNPYNCNODU-UHFFFAOYSA-N |
| Chemical Taxonomy | |
| Kingdom | Organic Compounds |
| Super Class | Heterocyclic Compounds |
| Class | Quinolines and Derivatives |
| Sub Class | Indoloquinolines |
| Direct Parent | Ergolines |
| Alternative Parents |
|
| Molecular Framework | Aromatic Heteropolycyclic Compounds |
| Substituents |
|
| External Descriptors | Not Available |
| External Links | |
| DrugBank ID | Not Available |
| PubChem Compound ID | 443884 ![]() |
| KEGG ID | Not Available |
| UniProt ID | Not Available |
| OMIM ID | Not Available |
| ChEBI ID | Not Available |
| BioCyc ID | Not Available |
| CTD ID | Not Available |
| Stitch ID | Not Available |
| PDB ID | Not Available |
| ACToR ID | Not Available |
| Wikipedia Link | http://en.wikipedia.org/wiki/Ergometrine ![]() |
| Physical Properties | |
| Appearance | Not Available |
| Melting Point | Not Available |
| Solubility | Not Available |
| Predicted LogP | 1.0706959856666662 |
| Toxicity Profile | |
| Route of Exposure | Oral, dermal, inhalation, and parenteral (contaminated drugs). (W967) |
| Mechanism of Action | Ergoline alkaloids tend to act as a group, producing complex and variable effects of partial agonism or antagonism at adrenergic, dopaminergic, and serotonergic receptors. Variables relating to these effects are influenced by the agent, dosage, species, tissue, physiological, and endocrinological state, and experimental conditions. In particular, ergoline alkaloids have been shown to have the significant affinity towards the 5-HT1 and 5-HT2 serotonin receptors, D1 and D2 dopamine receptors, and alpha-adrenergic receptors. This can result in a number of different effects, including vasoconstriction, convulsions, and hallucinations. Ergometrine is also known to have a non-receptor specific oxytocic activity. (W726, W727, W728) |
| Metabolism | Not Available |
| Toxicity Values | Not Available |
| Lethal Dose | Not Available |
| Carcinogenicity (IARC Classification) | Not Available |
| Uses/Sources | Ergoline alkaloids occur in various species of vines of the Convolvulaceae (morning glory) family and in some species of lower fungi. Ergometrine can also be synthesized from (+)-lysergic acid and L-(+)-2-aminopropanol. It has medical use in obstetrics to facilitate delivery of the placenta and to prevent bleeding after childbirth by causing smooth muscle tissue in the blood vessel walls to narrow, thereby reducing blood flow. For this is usually combined with oxytocin (Syntocinon) as syntometrine. (W721, W730) |
| Minimum Risk Level | Not Available |
| Health Effects | Ingestion of ergoline alkaloids is known to cause the disease ergotism. Ergotism occurs in two forms, gangrenous and convulsive, likely depending on the different kinds and amounts of ergoline alkaloids present. (W723) |
| Symptoms | Convulsive ergotism can cause painful seizures and spasms, diarrhea, paresthesias, itching, headaches, nausea and vomiting. Usually the gastrointestinal effects precede the central nervous system effects. As well as seizures there can be hallucinations and mental effects including mania or psychosis. Gangrenous ergotism causes dry gangrene as a result of vasoconstriction induced in the more poorly vascularized distal structures, such as the fingers and toes. Symptoms include desquamation, weak periphery pulse, loss of peripheral sensation, edema and ultimately the death and loss of affected tissues. (W724) |
| Treatment | Treatment for ergotism consists of vasodilators, anticoagulants and low molecular weight dextrans. If necessary, a sympathetic nerve blockade may be carried out, such as brachial plexus blockade. Temporary sedation (e.g. haloperidol) will be necessary in hallucination and diazepam is used for convulsions. There is no specific antidote. (W725) |
| References | |
| General References |
|
Targets
1. 5-hydroxytryptamine receptor 2A
This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. This receptor is involved in tracheal smooth muscle contraction, bronchoconstriction, and control of aldosterone production.
Ergometrine acts as an agonist at 5-HT2 receptors, causing direct stimulation of the uterine smooth musculature, resulting in increased muscular tone and an enhancement of the rate and force of rhythmical contractions. (W727)UniProt ID: P28223

Gene: HTR2A

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
2. 5-hydroxytryptamine receptor 2B
This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Plays a role in the regulation of impulsive behavior.
Ergometrine acts as an agonist at 5-HT2 receptors, causing direct stimulation of the uterine smooth musculature, resulting in increased muscular tone and an enhancement of the rate and force of rhythmical contractions. (W727)UniProt ID: P41595

Gene: HTR2B

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
3. 5-hydroxytryptamine receptor 2C
This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.
Ergometrine acts as an agonist at 5-HT2 receptors, causing direct stimulation of the uterine smooth musculature, resulting in increased muscular tone and an enhancement of the rate and force of rhythmical contractions. (W727)UniProt ID: P28335

Gene: HTR2C

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
4. D(2) dopamine receptor
Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity).
Ergometrine acts as an agonist at the D2 dopamine receptor, inhibiting cyclic AMP production. (W729)UniProt ID: P14416

Gene: DRD2

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W729 — Larson BT, Harmon DL, Piper EL, Griffis LM, Bush LP. Alkaloid binding and activation of D2 dopamine receptors in cell culture. J Anim Sci. 1999 Apr;77(4):942-7.
[10328360
]
5. Alpha-1A adrenergic receptor
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P35348

Gene: ADRA1A

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
6. Alpha-1B adrenergic receptor
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P35368

Gene: ADRA1B

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
7. Alpha-1D adrenergic receptor
This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P25100

Gene: ADRA1D

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
8. Alpha-2A adrenergic receptor
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P08913

Gene: ADRA2A

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
9. Alpha-2B adrenergic receptor
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine > norepinephrine > epinephrine = oxymetazoline > dopamine > p-tyramine = phenylephrine > serotonin > p-synephrine / p-octopamine. For antagonists, the rank order is yohimbine > chlorpromazine > phentolamine > mianserine > spiperone > prazosin > alprenolol > propanolol > pindolol.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P18089

Gene: ADRA2B

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]
10. Alpha-2C adrenergic receptor
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins.
Ergometrine is partitally agonistic of alpha-adrenergic receptors. (W727)UniProt ID: P18825

Gene: ADRA2C

Protein Sequence: FASTA
Gene Sequence: FASTA
SNPs: SNPJam Report

References:
- W727 — Schiff PL. Ergot and its alkaloids. Am J Pharm Educ. 2006 Oct 15;70(5):98.
[17149427
]